0.333

9.61% 0.0292

Applied Therapeutics Inc (APLT)

Overview News Price History Option Chain Financials Discussions Forecast

Applied Therapeutics Inc stock is traded at $0.333, with a volume of 1.78M. It is up +9.61% in the last 24 hours and down -39.06% over the past month. Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

Previous Close:

$0.3038

Open:

$0.3121

24h Volume:

1.78M

Relative Volume:

0.64

Market Cap:

$52.24M

Revenue:

Net Income/Loss:

$-119.76M

P/E Ratio:

-0.2467

EPS:

-1.35

Net Cash Flow:

$-55.17M

1W Performance:

+5.08%

1M Performance:

-39.06%

6M Performance:

-96.14%

1Y Performance:

-93.11%

1-Day Range:

$0.3121

$0.3463

1-Week Range:

$0.295

$0.384

52-Week Range:

$0.295

$10.62

Applied Therapeutics Inc Stock (APLT) Company Profile

Name

Applied Therapeutics Inc

Sector

Healthcare (1151)

Industry

Biotechnology (660)

Phone

212-220-9226

Address

545 FIFTH AVENUE, SUITE 1400, NEW YORK, NY

Employee

Twitter

@Applied_Tx

Next Earnings Date

2025-03-31

Latest SEC Filings

APLT's Discussions on Twitter

Compare APLT with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
APLT Applied Therapeutics Inc	0.333	52.24M	0	-119.76M	-55.17M	-1.35
VRTX Vertex Pharmaceuticals Inc	489.10	127.47B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	563.16	62.43B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	596.20	37.03B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	234.56	31.06B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	230.98	26.16B	3.81B	-644.79M	-669.77M	-6.24

Applied Therapeutics Inc Stock (APLT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-23-24	Downgrade	William Blair	Outperform → Mkt Perform
Dec-02-24	Downgrade	UBS	Buy → Neutral
Nov-29-24	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Jul-31-24	Initiated	William Blair	Outperform
Mar-26-24	Initiated	RBC Capital Mkts	Outperform
Feb-22-24	Initiated	Leerink Partners	Outperform
Jan-04-22	Downgrade	Barclays	Overweight → Equal Weight
Aug-27-21	Downgrade	Goldman	Neutral → Sell
Jun-25-21	Resumed	Goldman	Neutral
Oct-08-20	Initiated	Truist	Buy
Apr-22-20	Initiated	Goldman	Buy
Feb-27-20	Initiated	Barclays	Overweight
Jun-10-19	Initiated	Citigroup	Buy
Jun-10-19	Initiated	Cowen	Outperform
Jun-10-19	Initiated	Robert W. Baird	Outperform

View All

Applied Therapeutics Inc Stock (APLT) Latest News

Apr 16, 2025

APLT stock touches 52-week low at $0.3 amid sharp annual decline By Investing.com - Investing.com South Africa

Apr 16, 2025

APLT stock touches 52-week low at $0.3 amid sharp annual decline - Investing.com

Apr 16, 2025

Apr 15, 2025

Applied Therapeutics Reports 2024 Financial Results and Leadership Changes - TipRanks

Apr 15, 2025

Applied Therapeutics, Inc. SEC 10-K Report - TradingView

Apr 15, 2025

Applied Therapeutics (APLT) Reports Lower Revenue But Reinforces Strategic Focus | APLT Stock News - GuruFocus

Apr 15, 2025

Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Fi - GuruFocus

Apr 15, 2025

Apr 14, 2025

Applied Therapeutics earnings beat by $0.71, revenue fell short of estimates - Investing.com Canada

Apr 14, 2025

Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Financial Results - The Manila Times

Apr 14, 2025

Applied Therapeutics Strengthens Balance Sheet: $79.4M Cash Position Powers Drug Development Push - Stock Titan

Apr 14, 2025

Apr 13, 2025

Norges Bank Acquires New Shares in Applied Therapeutics, Inc. (NASDAQ:APLT) - Defense World

Apr 13, 2025

Apr 12, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics LawsuitAPLT - ACCESS Newswire

Apr 12, 2025

Apr 10, 2025

APLT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Apr 10, 2025

Apr 04, 2025

Shareholders that lost money on Applied Therapeutics, Inc.(APLT) should contact The Gross Law Firm about pending Class ActionAPLT - MarketScreener

Apr 04, 2025

Apr 03, 2025

APLT stock touches 52-week low at $0.42 amid sharp annual decline - Investing.com Australia

Apr 03, 2025

Investors Who Lost Money on Applied Therapeutics, Inc. (APLT) Should Contact Levi & Korsinsky About Pending Class ActionAPLT - ACCESS Newswire

Apr 03, 2025

APLT stock touches 52-week low at $0.42 amid sharp annual decline By Investing.com - Investing.com South Africa

Apr 03, 2025